223 related articles for article (PubMed ID: 26305481)
1. Decreased 11β-Hydroxysteroid Dehydrogenase 1 Level and Activity in Murine Pancreatic Islets Caused by Insulin-Like Growth Factor I Overexpression.
Chowdhury S; Grimm L; Gong YJ; Wang B; Li B; Srikant CB; Gao ZH; Liu JL
PLoS One; 2015; 10(8):e0136656. PubMed ID: 26305481
[TBL] [Abstract][Full Text] [Related]
2. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 11beta-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans.
Ortsäter H; Alberts P; Warpman U; Engblom LO; Abrahmsén L; Bergsten P
Diabetes Metab Res Rev; 2005; 21(4):359-66. PubMed ID: 15586384
[TBL] [Abstract][Full Text] [Related]
4. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
5. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
6. Regulation of 11beta-hydroxysteroid dehydrogenase 1 and 2 by IGF-1 in mice.
Huang Y; Li X; Lin H; Chu Y; Chen B; Lian Q; Ge RS
Biochem Biophys Res Commun; 2010 Jan; 391(4):1752-6. PubMed ID: 20045394
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11beta-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates.
Morita J; Hakuno F; Hizuka N; Takahashi S; Takano K
Endocr J; 2009; 56(4):561-70. PubMed ID: 19352050
[TBL] [Abstract][Full Text] [Related]
8. Regulation of 11β-HSD1 by GH/IGF-1 in key metabolic tissues may contribute to metabolic disease in GH deficient patients.
Morgan SA; Berryman DE; List EO; Lavery GG; Stewart PM; Kopchick JJ
Growth Horm IGF Res; 2022 Feb; 62():101440. PubMed ID: 34814007
[TBL] [Abstract][Full Text] [Related]
9. Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets.
Davani B; Khan A; Hult M; Mårtensson E; Okret S; Efendic S; Jörnvall H; Oppermann UC
J Biol Chem; 2000 Nov; 275(45):34841-4. PubMed ID: 10973946
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of repression of 11β-hydroxysteroid dehydrogenase type 1 by growth hormone in 3T3-L1 adipocytes.
Muraoka T; Hizuka N; Fukuda I; Ishikawa Y; Ichihara A
Endocr J; 2014; 61(7):675-82. PubMed ID: 24759003
[TBL] [Abstract][Full Text] [Related]
11. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
[TBL] [Abstract][Full Text] [Related]
12. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
[TBL] [Abstract][Full Text] [Related]
13. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
[TBL] [Abstract][Full Text] [Related]
14. Local cortisol/corticosterone activation in skin physiology and pathology.
Terao M; Katayama I
J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
[TBL] [Abstract][Full Text] [Related]
15. UVB induces epidermal 11β-hydroxysteroid dehydrogenase type 1 activity in vivo.
Tiganescu A; Hupe M; Jiang YJ; Celli A; Uchida Y; Mauro TM; Bikle DD; Elias PM; Holleran WM
Exp Dermatol; 2015 May; 24(5):370-6. PubMed ID: 25739654
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
Stewart PM; Toogood AA; Tomlinson JW
Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice.
Guo Y; Lu Y; Houle D; Robertson K; Tang Z; Kopchick JJ; Liu YL; Liu JL
Endocrinology; 2005 Jun; 146(6):2602-9. PubMed ID: 15731363
[TBL] [Abstract][Full Text] [Related]
18. Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1.
Man TY; Michailidou Z; Gokcel A; Ramage L; Chapman KE; Kenyon CJ; Seckl JR; Morton NM
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1076-84. PubMed ID: 21406612
[TBL] [Abstract][Full Text] [Related]
19. Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.
Turban S; Liu X; Ramage L; Webster SP; Walker BR; Dunbar DR; Mullins JJ; Seckl JR; Morton NM
Diabetes; 2012 Mar; 61(3):642-52. PubMed ID: 22315313
[TBL] [Abstract][Full Text] [Related]
20. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis.
Liu Y; Park F; Pietrusz JL; Jia G; Singh RJ; Netzel BC; Liang M
Physiol Genomics; 2008 Feb; 32(3):343-51. PubMed ID: 18073273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
